• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术方法对单发脑转移瘤患者并发症发生率和功能结局的影响。

Impact of surgical methodology on the complication rate and functional outcome of patients with a single brain metastasis.

作者信息

Patel Akash J, Suki Dima, Hatiboglu Mustafa Aziz, Rao Vikas Y, Fox Benjamin D, Sawaya Raymond

机构信息

Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center; and.

出版信息

J Neurosurg. 2015 May;122(5):1132-43. doi: 10.3171/2014.9.JNS13939. Epub 2015 Mar 20.

DOI:10.3171/2014.9.JNS13939
PMID:25794344
Abstract

OBJECT Brain metastases are the most common intracranial neoplasms and are on the increase. As radiation side effects are increasingly better understood, more patients are being treated with surgery alone with varying outcomes. The authors previously reported that en bloc resection of a single brain metastasis was associated with decreased incidences of leptomeningeal disease and local recurrence compared with piecemeal resection. However, en bloc resection is often feared to cause an increased incidence of postoperative complications. This study aimed to answer this question. METHODS The authors reviewed data from patients with a previously untreated single brain metastasis, who were treated with resection at The University of Texas M.D. Anderson Cancer Center (1993-2012). Data related to the patient, tumor, and methods of resection were obtained. Discharge Karnofsky Performance Scale (KPS) scores and 30-day postoperative complications were noted. Complications were considered major when they persisted for longer than 30 days, resulted in hospitalization or prolongation of hospital stay, required aggressive treatment, and/or were life threatening. RESULTS During the study period, 1033 eligible patients were identified. The median age was 58 years, 83% had a KPS score greater than 70, and 81% were symptomatic at surgery. Sixty-two percent of the patients underwent en bloc resection of their tumor, and 38% underwent piecemeal resection. There were significant differences between the 2 groups in terms of preoperative tumor volume, tumor functional grade, and symptoms at presentation, among others. The overall complication rates were 13% for patients undergoing en bloc resection and 19% for patients undergoing piecemeal resection (p = 0.007). The incidences of major complications and neurological complications were also significantly different. There was a trend in the same direction for major neurological complications, although it was not significant. Among patients undergoing piecemeal resection of tumors in eloquent cortex, 24% had complications (13% had major, 18% had neurological, 9% had major neurological, and 13% had select neurological complications; 4% died within 1 month of surgery). Among those undergoing en bloc resection of such tumors, 11% had complications (6% had major, 8% had neurological, 4% had major neurological, and 4% had select neurological; 2% died within 1 month of surgery). The differences in overall, major, neurological, and select neurological complications were statistically significant, but 1-month mortality and major neurological complications were not. In addition, within subcategories of tumor volume, the incidence of various complications was generally higher for patients undergoing piecemeal resection than for those undergoing en bloc resection. CONCLUSIONS The authors' results indicate that postoperative complication rates are not increased by en bloc resection, including for lesions in eloquent brain regions or for large tumors. This gives credence to the idea that en bloc resection of brain metastases, when feasible, is at least as safe as piecemeal resection.

摘要

目的 脑转移瘤是最常见的颅内肿瘤,且其发病率呈上升趋势。随着对放疗副作用的认识日益深入,越来越多的患者仅接受手术治疗,但其疗效各异。作者之前报道,与分块切除相比,整块切除单个脑转移瘤可降低软脑膜疾病和局部复发的发生率。然而,整块切除常被担心会导致术后并发症发生率增加。本研究旨在回答这一问题。方法 作者回顾了得克萨斯大学MD安德森癌症中心(1993 - 2012年)接受手术治疗的既往未经治疗的单个脑转移瘤患者的数据。获取了与患者、肿瘤及切除方法相关的数据。记录出院时的卡氏功能状态评分(KPS)及术后30天的并发症情况。当并发症持续超过30天、导致住院或延长住院时间、需要积极治疗和/或危及生命时,被视为严重并发症。结果 在研究期间,共确定了1033例符合条件的患者。中位年龄为58岁,83%的患者KPS评分大于70,81%的患者在手术时有症状。62%的患者接受了肿瘤整块切除,38%的患者接受了分块切除。两组在术前肿瘤体积、肿瘤功能分级及就诊时症状等方面存在显著差异。整块切除患者的总体并发症发生率为13%,分块切除患者为19%(p = 0.007)。严重并发症和神经并发症的发生率也有显著差异。严重神经并发症虽未达到显著水平,但也呈相同趋势。在优势脑皮质肿瘤分块切除的患者中,24%发生了并发症(13%为严重并发症,18%为神经并发症,9%为严重神经并发症,13%为特定神经并发症;4%在术后1个月内死亡)。在优势脑皮质肿瘤整块切除的患者中,11%发生了并发症(6%为严重并发症,8%为神经并发症,4%为严重神经并发症,4%为特定神经并发症;2%在术后1个月内死亡)。总体、严重、神经及特定神经并发症的差异具有统计学意义,但1个月死亡率和严重神经并发症差异无统计学意义。此外,在肿瘤体积亚组中,分块切除患者的各种并发症发生率总体上高于整块切除患者。结论 作者的结果表明,整块切除不会增加术后并发症发生率,包括优势脑区病变或大肿瘤。这支持了这样一种观点,即脑转移瘤在可行时进行整块切除至少与分块切除一样安全。

相似文献

1
Impact of surgical methodology on the complication rate and functional outcome of patients with a single brain metastasis.手术方法对单发脑转移瘤患者并发症发生率和功能结局的影响。
J Neurosurg. 2015 May;122(5):1132-43. doi: 10.3171/2014.9.JNS13939. Epub 2015 Mar 20.
2
Comparative risk of leptomeningeal dissemination of cancer after surgery or stereotactic radiosurgery for a single supratentorial solid tumor metastasis.单一幕上实体瘤转移灶手术后或立体定向放射治疗后软脑膜播散癌的比较风险。
Neurosurgery. 2009 Apr;64(4):664-74; discussion 674-6. doi: 10.1227/01.NEU.0000341535.53720.3E.
3
Factors influencing the risk of local recurrence after resection of a single brain metastasis.影响单个脑转移瘤切除后局部复发风险的因素。
J Neurosurg. 2010 Aug;113(2):181-9. doi: 10.3171/2009.11.JNS09659.
4
Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa.后颅窝实体瘤转移灶切除或立体定向放射治疗后软脑膜疾病的比较风险
J Neurosurg. 2008 Feb;108(2):248-57. doi: 10.3171/JNS/2008/108/2/0248.
5
The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?1229例胶质母细胞瘤患者最大安全切除对生存的影响:我们能否比全切除做得更好?
J Neurosurg. 2016 Apr;124(4):977-88. doi: 10.3171/2015.5.JNS142087. Epub 2015 Oct 23.
6
Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques.脑转移瘤治疗手术的重新评估:对一家机构采用现代神经外科技术治疗的208例单发或多发脑转移瘤患者的回顾。
Neurosurgery. 2005 May;56(5):1021-34; discussion 1021-34.
7
Outcomes following attempted en bloc resection of cervical chordomas in the C-1 and C-2 region versus the subaxial region: a multiinstitutional experience.C-1和C-2区域与轴下区域颈椎脊索瘤整块切除术后的结果:一项多机构研究经验
J Neurosurg Spine. 2014 Sep;21(3):348-56. doi: 10.3171/2014.5.SPINE121045. Epub 2014 Jun 13.
8
Surgical management of lateral-ventricle metastases: report of 29 cases in a single-institution experience.侧脑室转移瘤的外科治疗:单中心经验报告 29 例。
J Neurosurg. 2010 May;112(5):1046-55. doi: 10.3171/2009.7.JNS09571.
9
Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors.现代400例开颅手术治疗实质肿瘤的神经外科手术结果。
Neurosurgery. 1998 May;42(5):1044-55; discussion 1055-6. doi: 10.1097/00006123-199805000-00054.
10
Perioperative complication and surgical outcome in patients with spine metastases: retrospective 200-case series in a single institute.脊柱转移瘤患者的围手术期并发症及手术结果:单机构200例回顾性系列研究
Clin Neurol Neurosurg. 2014 Jul;122:80-6. doi: 10.1016/j.clineuro.2014.04.025. Epub 2014 May 6.

引用本文的文献

1
Supramarginal Resection of Metastatic Brain Tumors: A Meta-Analysis Study.转移性脑肿瘤的次全切除:一项荟萃分析研究
Medicina (Kaunas). 2025 Aug 12;61(8):1446. doi: 10.3390/medicina61081446.
2
Immune Checkpoint Inhibitors +/- Chemotherapy for Patients With NSCLC and Brain Metastases: A Systematic Review and Network Meta-Analysis.免疫检查点抑制剂联合或不联合化疗用于非小细胞肺癌合并脑转移患者:一项系统评价和网状Meta分析
Thorac Cancer. 2025 Jan;16(2):e15510. doi: 10.1111/1759-7714.15510.
3
Cancer neuroscience and glioma: clinical implications.
癌症神经科学与神经胶质瘤:临床意义
Acta Neurochir (Wien). 2025 Jan 3;167(1):2. doi: 10.1007/s00701-024-06406-2.
4
Lung cancer brain metastasis and hemorrhagic cerebral venous thrombosis: experiences and lessons.肺癌脑转移与出血性脑静脉血栓形成:经验与教训
Thromb J. 2024 Jul 11;22(1):61. doi: 10.1186/s12959-024-00629-0.
5
CSCO expert consensus on the diagnosis and treatment of breast cancer brain metastasis.中国临床肿瘤学会(CSCO)乳腺癌脑转移诊断和治疗专家共识
Transl Breast Cancer Res. 2022 Jul 30;3:22. doi: 10.21037/tbcr-22-30. eCollection 2022.
6
Clinical Practice Guidelines for Brain Metastasis From Solid Tumors.实体瘤脑转移的临床实践指南
Brain Tumor Res Treat. 2024 Jan;12(1):14-22. doi: 10.14791/btrt.2023.0049.
7
From Genes to Therapy: Pituitary Adenomas in the Era of Precision Medicine.从基因到治疗:精准医学时代的垂体腺瘤
Biomedicines. 2023 Dec 21;12(1):23. doi: 10.3390/biomedicines12010023.
8
Safety of microneurosurgical interventions for superficial and deep-seated brain metastases: single-center cohort study of 637 consecutive cases.脑转移瘤的微创神经外科干预的安全性:637 例连续病例的单中心队列研究。
J Neurooncol. 2023 Nov;165(2):271-278. doi: 10.1007/s11060-023-04478-1. Epub 2023 Nov 10.
9
Preoperative stereotactic radiosurgery as neoadjuvant therapy for resectable brain tumors.术前立体定向放射外科作为可切除脑肿瘤的新辅助治疗。
J Neurooncol. 2023 Oct;165(1):21-28. doi: 10.1007/s11060-023-04466-5. Epub 2023 Oct 27.
10
RAI-measured frailty predicts non-home discharge following metastatic brain tumor resection: national inpatient sample analysis of 20,185 patients.RAI 测量的虚弱程度可预测转移性脑肿瘤切除术后非居家出院:20185 例患者的全国住院患者样本分析。
J Neurooncol. 2023 Sep;164(3):663-670. doi: 10.1007/s11060-023-04461-w. Epub 2023 Oct 3.